Construction Materials
Compare Stocks
5 / 10Stock Comparison
SMID vs CSTE vs APOG vs TREX vs BLDR
Revenue, margins, valuation, and 5-year total return — side by side.
Construction
Construction
Construction
Construction
SMID vs CSTE vs APOG vs TREX vs BLDR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Construction Materials | Construction | Construction | Construction | Construction |
| Market Cap | $186M | $48M | $787M | $4.12B | $8.79B |
| Revenue (TTM) | $89M | $397M | $1.40B | $1.18B | $14.82B |
| Net Income (TTM) | $12M | $-137M | $54M | $191M | $292M |
| Gross Margin | 28.0% | 18.4% | 22.7% | 39.2% | 29.9% |
| Operating Margin | 17.6% | -14.8% | 6.7% | 22.1% | 4.2% |
| Forward P/E | 24.2x | — | 10.6x | 24.0x | 14.1x |
| Total Debt | $5M | $109M | $286M | $229M | $5.65B |
| Cash & Equiv. | $8M | — | $40M | $4M | $182M |
SMID vs CSTE vs APOG vs TREX vs BLDR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Smith-Midland Corpo… (SMID) | 100 | 729.6 | +629.6% |
| Caesarstone Ltd. (CSTE) | 100 | 12.4 | -87.6% |
| Apogee Enterprises,… (APOG) | 100 | 177.1 | +77.1% |
| Trex Company, Inc. (TREX) | 100 | 65.2 | -34.8% |
| Builders FirstSourc… (BLDR) | 100 | 381.9 | +281.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SMID vs CSTE vs APOG vs TREX vs BLDR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SMID carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 31.8%, EPS growth 8.7%, 3Y rev CAGR 15.7%
- 14.4% 10Y total return vs BLDR's 6.1%
- 31.8% revenue growth vs CSTE's -10.4%
- +14.2% vs CSTE's -39.2%
CSTE ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 1.25, Low D/E 78.6%, current ratio 1.83x
- Beta 1.25, current ratio 1.83x
- Beta 1.25 vs BLDR's 1.65, lower leverage
APOG is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 14 yrs, beta 1.25, yield 2.8%
- PEG 0.32 vs TREX's 7.16
- Lower P/E (10.6x vs 14.1x), PEG 0.32 vs 1.78
- 2.8% yield; 14-year raise streak; the other 4 pay no meaningful dividend
TREX is the clearest fit if your priority is quality.
- 16.3% margin vs CSTE's -34.6%
Among these 5 stocks, BLDR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.8% revenue growth vs CSTE's -10.4% | |
| Value | Lower P/E (10.6x vs 14.1x), PEG 0.32 vs 1.78 | |
| Quality / Margins | 16.3% margin vs CSTE's -34.6% | |
| Stability / Safety | Beta 1.25 vs BLDR's 1.65, lower leverage | |
| Dividends | 2.8% yield; 14-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +14.2% vs CSTE's -39.2% | |
| Efficiency (ROA) | 13.8% ROA vs CSTE's -27.9%, ROIC 21.2% vs -12.8% |
SMID vs CSTE vs APOG vs TREX vs BLDR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
SMID vs CSTE vs APOG vs TREX vs BLDR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SMID leads in 2 of 6 categories
TREX leads 1 • APOG leads 1 • CSTE leads 0 • BLDR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TREX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BLDR is the larger business by revenue, generating $14.8B annually — 166.8x SMID's $89M. TREX is the more profitable business, keeping 16.3% of every revenue dollar as net income compared to CSTE's -34.6%. On growth, APOG holds the edge at +1.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $89M | $397M | $1.4B | $1.2B | $14.8B |
| EBITDAEarnings before interest/tax | $18M | -$44M | $57M | $309M | $1.2B |
| Net IncomeAfter-tax profit | $12M | -$137M | $54M | $191M | $292M |
| Free Cash FlowCash after capex | $5M | -$46M | $95M | $263M | $862M |
| Gross MarginGross profit ÷ Revenue | +28.0% | +18.4% | +22.7% | +39.2% | +29.9% |
| Operating MarginEBIT ÷ Revenue | +17.6% | -14.8% | +6.7% | +22.1% | +4.2% |
| Net MarginNet income ÷ Revenue | +13.2% | -34.6% | +3.9% | +16.3% | +2.0% |
| FCF MarginFCF ÷ Revenue | +5.7% | -11.6% | +6.8% | +22.3% | +5.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.0% | -3.5% | +1.6% | +1.0% | -10.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -8.5% | -3.2% | +6.1% | +3.6% | -151.2% |
Valuation Metrics
Evenly matched — CSTE and APOG each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 14.5x trailing earnings, APOG trades at a 40% valuation discount to SMID's 24.2x P/E. Adjusting for growth (PEG ratio), APOG offers better value at 0.43x vs TREX's 6.58x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $186M | $48M | $787M | $4.1B | $8.8B |
| Enterprise ValueMkt cap + debt − cash | $183M | $157M | $1.0B | $4.3B | $14.3B |
| Trailing P/EPrice ÷ TTM EPS | 24.15x | -0.35x | 14.52x | 22.00x | 20.43x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 10.64x | 23.95x | 14.07x |
| PEG RatioP/E ÷ EPS growth rate | 0.79x | — | 0.43x | 6.58x | 2.59x |
| EV / EBITDAEnterprise value multiple | 14.60x | — | 21.95x | 13.53x | 10.35x |
| Price / SalesMarket cap ÷ Revenue | 2.37x | 0.12x | 0.56x | 3.51x | 0.58x |
| Price / BookPrice ÷ Book value/share | 4.45x | 0.34x | 1.53x | 4.05x | 2.04x |
| Price / FCFMarket cap ÷ FCF | — | — | 8.27x | 30.60x | 10.30x |
Profitability & Efficiency
SMID leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
SMID delivers a 22.6% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $-63 for CSTE. SMID carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to BLDR's 1.30x. On the Piotroski fundamental quality scale (0–9), SMID scores 7/9 vs CSTE's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +22.6% | -62.5% | +10.8% | +18.8% | +6.9% |
| ROA (TTM)Return on assets | +13.8% | -27.9% | +4.8% | +12.3% | +2.6% |
| ROICReturn on invested capital | +21.2% | -12.8% | +8.1% | +16.4% | +6.4% |
| ROCEReturn on capital employed | +20.1% | -15.6% | +9.7% | +23.2% | +8.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 2 | 7 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.12x | 0.79x | 0.56x | 0.22x | 1.30x |
| Net DebtTotal debt minus cash | -$2M | $109M | $247M | $225M | $5.5B |
| Cash & Equiv.Liquid assets | $8M | — | $40M | $4M | $182M |
| Total DebtShort + long-term debt | $5M | $109M | $286M | $229M | $5.6B |
| Interest CoverageEBIT ÷ Interest expense | 72.70x | -6.99x | 5.97x | — | 2.19x |
Total Returns (Dividends Reinvested)
SMID leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SMID five years ago would be worth $26,938 today (with dividends reinvested), compared to $1,097 for CSTE. Over the past 12 months, SMID leads with a +14.2% total return vs CSTE's -39.2%. The 3-year compound annual growth rate (CAGR) favors SMID at 29.0% vs CSTE's -33.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.6% | -20.2% | -1.3% | +9.3% | -24.0% |
| 1-Year ReturnPast 12 months | +14.2% | -39.2% | -2.8% | -30.8% | -25.0% |
| 3-Year ReturnCumulative with dividends | +114.7% | -70.0% | -0.1% | -30.4% | -30.1% |
| 5-Year ReturnCumulative with dividends | +169.4% | -89.0% | +12.9% | -64.0% | +51.8% |
| 10-Year ReturnCumulative with dividends | +1436.8% | -92.7% | +10.5% | +239.9% | +614.8% |
| CAGR (3Y)Annualised 3-year return | +29.0% | -33.1% | -0.0% | -11.4% | -11.2% |
Risk & Volatility
Evenly matched — SMID and CSTE each lead in 1 of 2 comparable metrics.
Risk & Volatility
CSTE is the less volatile stock with a 1.25 beta — it tends to amplify market swings less than BLDR's 1.65 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SMID currently trades 80.2% from its 52-week high vs BLDR's 52.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.58x | 1.25x | 1.25x | 1.47x | 1.65x |
| 52-Week HighHighest price in past year | $43.66 | $2.58 | $49.99 | $68.78 | $151.03 |
| 52-Week LowLowest price in past year | $25.56 | $0.56 | $30.75 | $29.77 | $73.40 |
| % of 52W HighCurrent price vs 52-week peak | +80.2% | +53.5% | +73.2% | +56.9% | +52.6% |
| RSI (14)Momentum oscillator 0–100 | 58.1 | 49.0 | 53.6 | 51.3 | 42.8 |
| Avg Volume (50D)Average daily shares traded | 9K | 1.3M | 253K | 1.7M | 2.4M |
Analyst Outlook
APOG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: APOG as "Hold", TREX as "Hold", BLDR as "Buy". Consensus price targets imply 92.7% upside for APOG (target: $71) vs 13.6% for TREX (target: $45). APOG is the only dividend payer here at 2.83% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $70.50 | $44.50 | $109.92 |
| # AnalystsCovering analysts | — | — | 6 | 31 | 43 |
| Dividend YieldAnnual dividend ÷ price | — | — | +2.8% | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | 14 | 2 | 2 |
| Dividend / ShareAnnual DPS | — | — | $1.04 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.9% | +1.3% | +4.7% |
SMID leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). TREX leads in 1 (Income & Cash Flow). 2 tied.
SMID vs CSTE vs APOG vs TREX vs BLDR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SMID or CSTE or APOG or TREX or BLDR a better buy right now?
For growth investors, Smith-Midland Corporation (SMID) is the stronger pick with 31.
8% revenue growth year-over-year, versus -10. 4% for Caesarstone Ltd. (CSTE). Apogee Enterprises, Inc. (APOG) offers the better valuation at 14. 5x trailing P/E (10. 6x forward), making it the more compelling value choice. Analysts rate Builders FirstSource, Inc. (BLDR) a "Buy" — based on 43 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SMID or CSTE or APOG or TREX or BLDR?
On trailing P/E, Apogee Enterprises, Inc.
(APOG) is the cheapest at 14. 5x versus Smith-Midland Corporation at 24. 2x. On forward P/E, Apogee Enterprises, Inc. is actually cheaper at 10. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Apogee Enterprises, Inc. wins at 0. 32x versus Trex Company, Inc. 's 7. 16x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SMID or CSTE or APOG or TREX or BLDR?
Over the past 5 years, Smith-Midland Corporation (SMID) delivered a total return of +169.
4%, compared to -89. 0% for Caesarstone Ltd. (CSTE). Over 10 years, the gap is even starker: SMID returned +1437% versus CSTE's -92. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SMID or CSTE or APOG or TREX or BLDR?
By beta (market sensitivity over 5 years), Caesarstone Ltd.
(CSTE) is the lower-risk stock at 1. 25β versus Builders FirstSource, Inc. 's 1. 65β — meaning BLDR is approximately 32% more volatile than CSTE relative to the S&P 500. On balance sheet safety, Smith-Midland Corporation (SMID) carries a lower debt/equity ratio of 12% versus 130% for Builders FirstSource, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SMID or CSTE or APOG or TREX or BLDR?
By revenue growth (latest reported year), Smith-Midland Corporation (SMID) is pulling ahead at 31.
8% versus -10. 4% for Caesarstone Ltd. (CSTE). On earnings-per-share growth, the picture is similar: Smith-Midland Corporation grew EPS 866. 7% year-over-year, compared to -252. 2% for Caesarstone Ltd.. Over a 3-year CAGR, SMID leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SMID or CSTE or APOG or TREX or BLDR?
Trex Company, Inc.
(TREX) is the more profitable company, earning 16. 2% net margin versus -34. 6% for Caesarstone Ltd. — meaning it keeps 16. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TREX leads at 22. 0% versus -12. 9% for CSTE. At the gross margin level — before operating expenses — TREX leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SMID or CSTE or APOG or TREX or BLDR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Apogee Enterprises, Inc. (APOG) is the more undervalued stock at a PEG of 0. 32x versus Trex Company, Inc. 's 7. 16x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Apogee Enterprises, Inc. (APOG) trades at 10. 6x forward P/E versus 24. 0x for Trex Company, Inc. — 13. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for APOG: 92. 7% to $70. 50.
08Which pays a better dividend — SMID or CSTE or APOG or TREX or BLDR?
In this comparison, APOG (2.
8% yield) pays a dividend. SMID, CSTE, TREX, BLDR do not pay a meaningful dividend and should not be held primarily for income.
09Is SMID or CSTE or APOG or TREX or BLDR better for a retirement portfolio?
For long-horizon retirement investors, Smith-Midland Corporation (SMID) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1437% 10Y return).
Both have compounded well over 10 years (SMID: +1437%, CSTE: -92. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SMID and CSTE and APOG and TREX and BLDR?
These companies operate in different sectors (SMID (Basic Materials) and CSTE (Industrials) and APOG (Industrials) and TREX (Industrials) and BLDR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SMID is a small-cap high-growth stock; CSTE is a small-cap quality compounder stock; APOG is a small-cap deep-value stock; TREX is a small-cap quality compounder stock; BLDR is a small-cap quality compounder stock. APOG pays a dividend while SMID, CSTE, TREX, BLDR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.